Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-12-31 | David Aviezer, Ph.D., MBA. Dr. Aviezer has served as Chief Executive Officer of Protalix Ltd. since 2002 and its director since 2005 and as our director since December 31, 2006. On December 31, 2006, he became our President and Chief Executive Officer. |
| 2008-10-03 | David Aviezer, Ph.D., MBA. Dr. Aviezer has served as Chief Executive Officer of Protalix Ltd. since 2002 and its director since 2005, and as our director since December 31, 2006. On December 31, 2006, he became our President and Chief Executive Officer. Dr. Aviezer has over a decade of experience in biotechnology management, advancing products from early-stage research up to their regulatory approval and commercialization. Prior to joining Protalix Ltd., from 1996 to 2002, he served as general manager of ProChon Biotech Ltd., an Israeli company focused on orthopedic disorders. Previously, Dr. Aviezer was a visiting scientist at the Medical Research Division of American Cyanamid, a subsidiary of Wyeth (NYSE:WEY), in New York. Since 1996, Dr. Aviezer has served as an adjunct lecturer at Bar Ilan University. Dr. Aviezer is the recipient of the Clore Foundation Award and the J.F. Kennedy Scientific Award. He received a Ph.D. in Molecular Biology and Biochemistry from the Weizmann Institute of Science and an M.B.A. from the Bar Ilan University Business School. |
| 2009-09-18 | David Aviezer, Ph.D., MBA. Dr. Aviezer has served as Chief Executive Officer of Protalix Ltd. since 2002 and its director since 2005 and as our director since December 31, 2006. On December 31, 2006, he became our President and Chief Executive Officer. |
| 2010-10-04 | David Aviezer, Ph.D., MBA. Dr. Aviezer has served as Chief Executive Officer of Protalix Ltd. since 2002 and its director since 2005 and as our director since December 31, 2006. On December 31, 2006, he became our President and Chief Executive Officer. ... The following table sets forth a summary of the cash and non-cash compensation awarded, paid or accrued by us or Protalix Ltd. to each of our President and Chief Executive Officer ... David Aviezer, Ph.D., MBA 2009 427,970 500,000 529,951 62,167 1,520,088 |
| 2011-09-19 | David Aviezer, Ph.D., MBA 46 Director, President and Chief Executive Officer ... Dr. Aviezer has served as Chief Executive Officer ... ... The following table sets forth information ... Name Age Position David Aviezer, Ph.D., MBA 46 Director, President and Chief Executive Officer ... Compensation of Directors ... ... The following table sets forth information with respect to compensation ... ... Our Board of Directors will review director compensation annually ... ... Dr. Aviezer originally served as Protalix Ltd.'s Chief Executive Officer on a consultancy basis ... ... Dr. Aviezer's current monthly base salary is NIS 148,000 (approximately $40,152) ... ... Dr. Aviezer is entitled to be insured by Protalix Ltd. under a Manager's Policy in lieu of severance ... ... Dr. Aviezer is entitled to 24 working days of vacation. |
| 2013-09-20 | David Aviezer, Ph.D., MBA 48 Director, President and Chief Executive Officer ...Dr. Aviezer has served as Chief Executive Officer of Protalix Ltd. since 2002 and its director since 2005 and as our director since December 31, 2006. On December 31, 2006, he became our President and Chief Executive Officer. |
Data sourced from SEC filings. Last updated: 2026-02-08